vs

Side-by-side financial comparison of CME Group (CME) and Seagate Technology (STX). Click either name above to swap in a different company.

Seagate Technology is the larger business by last-quarter revenue ($3.1B vs $1.9B, roughly 1.7× CME Group). Seagate Technology runs the higher net margin — 24.0% vs 0.1%, a 24.0% gap on every dollar of revenue. On growth, Seagate Technology posted the faster year-over-year revenue change (44.1% vs 14.5%). Over the past eight quarters, Seagate Technology's revenue compounded faster (28.4% CAGR vs 10.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Seagate Technology Holdings plc is an American data storage company. It was incorporated in 1978 as Shugart Technology and commenced business in 1979. Since 2010, the company has been incorporated in Dublin, Ireland, with operational headquarters in Fremont, California, United States.

CME vs STX — Head-to-Head

Bigger by revenue
STX
STX
1.7× larger
STX
$3.1B
$1.9B
CME
Growing faster (revenue YoY)
STX
STX
+29.6% gap
STX
44.1%
14.5%
CME
Higher net margin
STX
STX
24.0% more per $
STX
24.0%
0.1%
CME
Faster 2-yr revenue CAGR
STX
STX
Annualised
STX
28.4%
10.8%
CME

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
CME
CME
STX
STX
Revenue
$1.9B
$3.1B
Net Profit
$1.2M
$748.0M
Gross Margin
46.5%
Operating Margin
0.1%
32.1%
Net Margin
0.1%
24.0%
Revenue YoY
14.5%
44.1%
Net Profit YoY
20.7%
-23.8%
EPS (diluted)
$3.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
STX
STX
Q3 26
$3.1B
Q1 26
$1.9B
$2.8B
Q4 25
$1.6B
$2.6B
Q3 25
$1.5B
Q2 25
$1.7B
$2.4B
Q1 25
$1.6B
$2.2B
Q4 24
$1.5B
$2.3B
Q3 24
$1.6B
$2.2B
Net Profit
CME
CME
STX
STX
Q3 26
$748.0M
Q1 26
$1.2M
$593.0M
Q4 25
$1.2B
$549.0M
Q3 25
$908.0M
Q2 25
$1.0B
$488.0M
Q1 25
$956.2M
$340.0M
Q4 24
$874.6M
$336.0M
Q3 24
$912.8M
$305.0M
Gross Margin
CME
CME
STX
STX
Q3 26
46.5%
Q1 26
41.6%
Q4 25
39.4%
Q3 25
Q2 25
37.4%
Q1 25
35.2%
Q4 24
34.9%
Q3 24
32.9%
Operating Margin
CME
CME
STX
STX
Q3 26
32.1%
Q1 26
0.1%
29.8%
Q4 25
61.8%
26.4%
Q3 25
63.3%
Q2 25
66.7%
23.2%
Q1 25
67.5%
20.0%
Q4 24
62.1%
21.0%
Q3 24
64.6%
18.6%
Net Margin
CME
CME
STX
STX
Q3 26
24.0%
Q1 26
0.1%
21.0%
Q4 25
71.7%
20.9%
Q3 25
59.1%
Q2 25
60.6%
20.0%
Q1 25
58.2%
15.7%
Q4 24
57.3%
14.5%
Q3 24
57.6%
14.1%
EPS (diluted)
CME
CME
STX
STX
Q3 26
$3.27
Q1 26
$2.60
Q4 25
$3.24
$2.43
Q3 25
$2.49
Q2 25
$2.81
$2.24
Q1 25
$2.62
$1.57
Q4 24
$2.40
$1.55
Q3 24
$2.50
$1.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
STX
STX
Cash + ST InvestmentsLiquidity on hand
$2.4B
$1.1B
Total DebtLower is stronger
$3.4B
$3.9B
Stockholders' EquityBook value
Total Assets
$202.0B
$8.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
STX
STX
Q3 26
$1.1B
Q1 26
$2.4B
$1.0B
Q4 25
$4.5B
$1.1B
Q3 25
$2.6B
Q2 25
$2.1B
$891.0M
Q1 25
$1.5B
$814.0M
Q4 24
$3.0B
$1.2B
Q3 24
$2.4B
$1.2B
Total Debt
CME
CME
STX
STX
Q3 26
$3.9B
Q1 26
$3.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Stockholders' Equity
CME
CME
STX
STX
Q3 26
Q1 26
$459.0M
Q4 25
$28.7B
$-63.0M
Q3 25
$28.2B
Q2 25
$27.7B
$-453.0M
Q1 25
$27.0B
$-829.0M
Q4 24
$26.5B
$-1.1B
Q3 24
$28.2B
$-1.3B
Total Assets
CME
CME
STX
STX
Q3 26
$8.9B
Q1 26
$202.0B
$8.7B
Q4 25
$198.4B
$8.4B
Q3 25
$187.1B
Q2 25
$179.9B
$8.0B
Q1 25
$157.8B
$7.6B
Q4 24
$137.4B
$8.0B
Q3 24
$137.8B
$8.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
STX
STX
Operating Cash FlowLast quarter
$2.4B
Free Cash FlowOCF − Capex
$953.0M
FCF MarginFCF / Revenue
30.6%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.17×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
STX
STX
Q3 26
$2.4B
Q1 26
Q4 25
$1.1B
$532.0M
Q3 25
$968.1M
Q2 25
$1.1B
$508.0M
Q1 25
$1.1B
$259.0M
Q4 24
$1.0B
$221.0M
Q3 24
$1.0B
$95.0M
Free Cash Flow
CME
CME
STX
STX
Q3 26
$953.0M
Q1 26
Q4 25
$1.1B
$427.0M
Q3 25
$949.7M
Q2 25
$1.0B
$425.0M
Q1 25
$1.1B
$216.0M
Q4 24
$991.7M
$150.0M
Q3 24
$973.2M
$27.0M
FCF Margin
CME
CME
STX
STX
Q3 26
30.6%
Q1 26
Q4 25
66.8%
16.2%
Q3 25
61.8%
Q2 25
61.5%
17.4%
Q1 25
67.1%
10.0%
Q4 24
65.0%
6.5%
Q3 24
61.4%
1.2%
Capex Intensity
CME
CME
STX
STX
Q3 26
Q1 26
Q4 25
2.0%
4.0%
Q3 25
1.2%
Q2 25
1.1%
3.4%
Q1 25
0.9%
2.0%
Q4 24
1.7%
3.1%
Q3 24
1.9%
3.1%
Cash Conversion
CME
CME
STX
STX
Q3 26
3.17×
Q1 26
Q4 25
0.96×
0.97×
Q3 25
1.07×
Q2 25
1.03×
1.04×
Q1 25
1.17×
0.76×
Q4 24
1.16×
0.66×
Q3 24
1.10×
0.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons